REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Next Gen Probiotics Sp. z o.o. sp. k. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Next Gen Probiotics Sp. z o.o. sp. k. Profile Updated: July 06, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2020 Available in: English & Polish Download a sample report

Next Gen Probiotics Sp. z o.o. sp. k. is a company based in Poland, with its head office in Poznan. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was established on February 07, 2018. Its’ total assets recorded a growth of 26.94%.

Headquarters
Ul. Jana Henryka Dabrowskiego 286/288
Poznan; Wielkopolskie; Postal Code: 60-406

Contact Details: Purchase the Next Gen Probiotics Sp. z o.o. sp. k. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Next Gen Probiotics Sp. z o.o. sp. k. report to view the information.
Incorporation Date:
February 07, 2018
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Purchase this report to view the information.
Limited Partner
Ownership Details
Purchase this report to view the information.
33.3333%
Purchase this report to view the information.
33.3333%
Purchase this report to view the information.
33.3333%
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Next Gen Probiotics Sp. z o.o. sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
48.95%▲
Net Profit (Loss) for the Period
48.95%▲
Total assets
26.94%▲
Total equity
47.49%▲
Return on Equity (ROE)
193.58%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo